https://www.selleckchem.com/pr....oducts/defactinib.ht
Baseline MetS was also associated with an increase in the number of IADL (beta = 0.15, 95% CI 0.07-0.23) and ADL limitations (beta = 0.10, 95% CI 0.01-0.18), while adjusting for baseline functional performance. Significant MetS component predictors of disability outcomes include abdominal obesity, high blood pressure, and a low level of high-density lipoprotein cholesterol. Our findings suggest an increased risk of incident disability and deteriorated functional performance over 4years, associated with the presence of MetS and its co
Like
Comment
Share
